NCT03136770

A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K)

A Randomized, Open-label, Two-way Crossover Study to Assess the Pharmacokinetics and Safety of CK-30 600 mg (Compound K) and Red Ginseng Extracts 2.94 g After a Single Oral Dose in Healthy Male Volunteers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 25 (actual)
• Sponsor: Seoul National University Hospital · Academic / Other
• Sex: Male
• Age: 19 Years – 45 Years
• Healthy volunteers: Accepted

Summary

A study to assess the pharmacokinetics and safety of CK-30 600 mg (Compound K) and red ginseng extracts 2.94 g after a single oral dose in healthy male volunteers

Conditions

• Pharmacokinetics

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	CK-30	Compound K 600 mg
DIETARY_SUPPLEMENT	Red ginseng extracts	Red ginseng extracts 2.94 g

Timeline

• Start date: 2017-02-15
• Primary completion: 2017-04-10
• Completion: 2017-04-10
• First posted: 2017-05-02
• Last updated: 2017-05-02

Locations

1 site across 1 country: South Korea